Drug Shortage Report for TEGRETOL SUSPENSION
| Report ID | 152535 |
| Drug Identification Number | 02194333 |
| Brand name | TEGRETOL SUSPENSION |
| Common or Proper name | TEGRETOL SUSPENSION 100MG/5ML 450ML |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CARBAMAZEPINE |
| Strength(s) | 100MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 450ML |
| ATC code | N03AF |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2022-01-12 |
| Actual start date | 2022-01-06 |
| Estimated end date | 2022-02-14 |
| Actual end date | 2022-03-03 |
| Shortage status | Resolved |
| Updated date | 2022-03-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2022-03-04 | English | Compare |
| v4 | 2022-03-03 | French | Compare |
| v3 | 2022-03-03 | English | Compare |
| v2 | 2022-01-12 | French | Compare |
| v1 | 2022-01-12 | English | Compare |
Showing 1 to 5 of 5